Developing Data-Driven Policies To Cure and Prevent Age-Related Diseases
Developing Data-Driven Policies To Cure and Prevent Age-Related Diseases
Sunday, 15 February 2015: 1:30 PM-4:30 PM
Room LL21D (San Jose Convention Center)
The United States faces a paradox in health strategy: we have at hand more financial and intellectual resources than ever, yet innovation lags on new drugs and devices and effective management of chronic conditions remains elusive. Why is this happening? The U.S. commitment to expand health coverage coincides with increased prevalence and projected growth for chronic diseases -- diabetes, chronic obstructive pulmonary disease, Alzheimer’s, and other neurodegenerative diseases, just to name a few. These diseases are poised to devour future national, community, and family resources. Can medical research turn this tide? An explosive growth in personal medical data promises to enable innovation, but is the research community and the U.S. Food and Drug Administration’s regulatory system really up for that? Can the health care delivery system simultaneously adapt to changing business models and achieve culturally, economically, and politically sustainable results, e.g., cures? And will privacy, security, and legal concerns smother even modest ambitions?
Organizer:
Sharotka Simon, AAAS Science and Technology Policy Fellow, Diplomacy, Security, and Development Program
Speakers:
